Live
- Modi congratulates Starmer, praises Sunak’s leadership
- Keir Starmer becomes UK PM
- All set for Jagannath Rath Yatra in city tomorrow
- Take steps to curb red sanders smuggling says Dy CM Pawan Kalyan
- Vijayawada: IT Minister Lokesh promises investor-friendly IT policy soon
- Grand welcome to Naidu in Hyd
- Thinking outside the box with…Open mind
- MyVoice: Views of our readers 6th July 2024
- Vijayawada: Pawan Kalyan performs Aditya Aradhana
- The Return of The King
Just In
13-Year-Old With Incurable Cancer Is Saved by Gene Therapy
Hans News Service | 13 Dec 2022 7:15 AM GMT
x
Highlights
- An innovative gene therapy developed by researchers in the UK has been used to treat a young patient with relapsed T-cell leukaemia.
- The usual methods or therapies used earlier got a turn when the 13-year-old Leicester resident Alyssa received the experimental treatment.
According to sources, an innovative gene therapy developed by researchers in the UK has been used to treat a young patient with relapsed T-cell leukaemia. The procedure, which was used for the first time ever, may potentially provide a means to treat different types of paediatric tumours.
Usually the T-cell leukaemia is a type of cancer that affects a subset of white blood cells known as T-cells. Their growth is hampered by the illness, which also has an impact on the body's blood cell production. Chemotherapy and bone marrow transplants are typically recommended as therapies for this.
The usual methods or therapies used earlier got a turn when the 13-year-old Leicester resident Alyssa received the experimental treatment. Her prior attempts to treat her cancer with chemotherapy and a bone marrow transplant didn't have the same degree of effectiveness. Sadly, no more treatments were available, therefore she had a very unclear future.
The new method of treatment, however, included injecting a patient with donated T-cells that had been modified so that they would kill other T-cells, including her leukaemia cells. This was accomplished utilising base editing, which allowed researchers to make a single modification to the enormous number of DNA letters that make up a person's genetic code.
Alyssa has been free of leukaemia for more than six months thanks to the new treatment, which included a second bone marrow transplant to rebuild her immune system.
Furthermore, ten more T-cell leukaemia patients without access to any other therapy are being sought by researchers at London's Great Ormond Street Hospital who treated Alyssa.
Next Story
More Stories
ADVERTISEMENT
© 2024 Hyderabad Media House Limited/The Hans India. All rights reserved. Powered by hocalwire.com